Successful use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: M. Grace Hren, Sophie Guenin, Saakshi Khattri Source Type: research
More News: Academies | Arthritis | Dermatitis | Dermatology | Inflammatory Bowel Disease | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin